Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent advances in antimalarial drug development.

Suryanaryana Vangapandu1, Meenakshi Jain, Kirandeep Kaur

  • 1Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research, Sector 67, S.A.S. Nagar, Punjab 160 062, India.

Medicinal Research Reviews
|May 16, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sustainable diets and functional foods for the prevention of cardio-metabolic diseases and sustainable development goals of the UNO. An international consensus of scientific statement of the international college of nutrition and 28th world congress on clinical nutrition, Bogor, Indonesia.

BMC cardiovascular disorders·2026
Same author

Environmental pollutants as vascular poisons: rethinking mesenteric ischemia through the lens of heavy metal toxicity.

Journal of environmental science and health. Part C, Toxicology and carcinogenesis·2026
Same author

Young onset hypertension - underdiagnosed and undertreated - a rare case presentation.

Journal of family medicine and primary care·2026
Same author

Cytokine levels in serum and cerebrospinal fluid of patients with idiopathic intracranial hypertension.

Brain research·2026
Same author

Artificial intelligence in ophthalmology: from innovation to clinical integration.

Frontiers in ophthalmology·2026
Same author

Artificial intelligence in retinoblastoma and uveal melanoma - a narrative review.

Expert review of anticancer therapy·2026

Malaria drug resistance necessitates new treatments. This review details significant advancements in antimalarial drug development over the last decade, focusing on novel agents and re-evaluating existing drugs against resistant Plasmodium strains.

Area of Science:

  • Infectious Diseases
  • Parasitology
  • Pharmacology

Background:

  • Malaria, caused by Plasmodium parasites, remains a major global health threat due to its widespread nature, severity, and increasing drug resistance.
  • Current antimalarial drug options are limited, and resistance to widely used medications like chloroquine is a significant challenge.
  • The lack of affordable and effective new antimalarial drugs hinders global efforts to control the disease.

Purpose of the Study:

  • To review significant progress in antimalarial drug development over the past 10 years.
  • To highlight the urgent need for novel antimalarial agents.
  • To explore the potential of existing antimalarial drugs against resistant Plasmodium strains.

Main Methods:

  • Comprehensive literature search of antimalarial drug development research published in the last decade.

Related Experiment Videos

  • Analysis of studies focusing on new antimalarial drug classes.
  • Evaluation of research on existing antimalarial drugs' efficacy against resistant strains.

    • Main Results:

    • Identification of emerging classes of antimalarial compounds.
    • Assessment of novel therapeutic strategies targeting Plasmodium parasites.
    • Review of updated information on drug resistance patterns and mechanisms.

    Conclusions:

    • Continued research into new antimalarial drug classes is crucial.
    • Re-evaluation of existing antimalarial drugs may yield effective treatments for resistant malaria.
    • Addressing drug resistance and affordability is key to combating malaria globally.